These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 38651063)

  • 1. Case report: Cerebral sinus vein thrombosis in VEXAS syndrome.
    Zisapel M; Seyman E; Molad J; Hallevi H; Mauda-Havakuk M; Jonas-Kimchi T; Elkayam O; Eviatar T
    Front Med (Lausanne); 2024; 11():1377768. PubMed ID: 38651063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Venous and arterial thrombosis in patients with VEXAS syndrome.
    Kusne Y; Ghorbanzadeh A; Dulau-Florea A; Shalhoub R; Alcedo PE; Nghiem K; Ferrada MA; Hines A; Quinn KA; Panicker SR; Ombrello AK; Reichard K; Darden I; Goodspeed W; Durrani J; Wilson L; Olteanu H; Lasho T; Kastner DL; Warrington KJ; Mangaonkar A; Go RS; Braylan RC; Beck DB; Patnaik MM; Young NS; Calvo KR; Casanegra AI; Grayson PC; Koster MJ; Wu CO; Kanthi Y; Patel BA; Houghton DE; Groarke EM
    Blood; 2024 May; 143(21):2190-2200. PubMed ID: 38306657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombosis in VEXAS syndrome.
    Oo TM; Koay JTJ; Lee SF; Lee SMS; Lim XR; Fan BE
    J Thromb Thrombolysis; 2022 May; 53(4):965-970. PubMed ID: 34817788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thrombotic manifestations of VEXAS syndrome.
    Groarke EM; Dulau-Florea AE; Kanthi Y
    Semin Hematol; 2021 Oct; 58(4):230-238. PubMed ID: 34802545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic syndrome (VEXAS syndrome) with prominent supraglottic larynx involvement: a case-based review.
    Guerrero-Bermúdez CA; Cardona-Cardona AF; Ariza-Parra EJ; Arostegui JI; Mensa-Vilaro A; Yague J; Vásquez G; Muñoz-Vahos CH
    Clin Rheumatol; 2022 Nov; 41(11):3565-3572. PubMed ID: 35986821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pulmonary manifestations in VEXAS (vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic) syndrome: a systematic review.
    Kouranloo K; Ashley A; Zhao SS; Dey M
    Rheumatol Int; 2023 Jun; 43(6):1023-1032. PubMed ID: 36617363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vacuoles, E1 enzyme, X-linked, autoinflammatory, and somatic syndrome in the intensive care unit: a case report.
    Belicard F; Belhomme N; Bouzy S; Saillard C; Nedelec F; Mear JB; Ardois S; Pastoret C; Reizine F; Camus C; Painvin B
    J Med Case Rep; 2023 Jul; 17(1):314. PubMed ID: 37480098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. VEXAS syndrome: a new paradigm for adult-onset monogenic autoinflammatory diseases.
    Vitale A; Caggiano V; Bimonte A; Caroni F; Tosi GM; Fabbiani A; Renieri A; Bocchia M; Frediani B; Fabiani C; Cantarini L
    Intern Emerg Med; 2023 Apr; 18(3):711-722. PubMed ID: 36662445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic (VEXAS) syndrome presenting as recurrent aseptic peritonitis in a patient receiving peritoneal dialysis: a case report.
    Fukuda N; Kanai D; Hoshino K; Fukuda Y; Morita R; Ishikawa Y; Kanaoka T; Toya Y; Kirino Y; Wakui H; Tamura K
    BMC Nephrol; 2024 Jan; 25(1):18. PubMed ID: 38212709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. VEXAS Syndrome-Review.
    Zhang Y; Dong X; Wang H
    Glob Med Genet; 2023 Sep; 10(3):133-143. PubMed ID: 37501758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Budd-Chiari syndrome: a common complication of Behçet's disease.
    Bayraktar Y; Balkanci F; Bayraktar M; Calguneri M
    Am J Gastroenterol; 1997 May; 92(5):858-62. PubMed ID: 9149201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tocilizumab for treatment of cutaneous and systemic manifestations of vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic (VEXAS) syndrome without myelodysplastic syndrome.
    Goyal A; Narayanan D; Wong W; Laga AC; Connell NT; Ritter SY; Cobos G
    JAAD Case Rep; 2022 May; 23():15-19. PubMed ID: 35391910
    [No Abstract]   [Full Text] [Related]  

  • 13. Pleuropulmonary Manifestations of Vacuoles, E1 Enzyme, X-Linked, Autoinflammatory, Somatic (VEXAS) Syndrome.
    Borie R; Debray MP; Guedon AF; Mekinian A; Terriou L; Lacombe V; Lazaro E; Meyer A; Mathian A; Ardois S; Vial G; Moulinet T; Terrier B; Jamilloux Y; Heiblig M; Bouaziz JD; Zakine E; Outh R; Groslerons S; Bigot A; Flamarion E; Kostine M; Henneton P; Humbert S; Constantin A; Samson M; Bertrand NM; Biscay P; Dieval C; Lobbes H; Jeannel J; Servettaz A; Adelaide L; Graveleau J; de Sainte-Marie B; Galland J; Guillotin V; Duroyon E; Templé M; Bourguiba R; Georgin Lavialle S; Kosmider O; Audemard-Verger A;
    Chest; 2023 Mar; 163(3):575-585. PubMed ID: 36272567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Case of VEXAS: Vacuoles, E1 Enzyme, X-linked, Autoinflammatory, Somatic Syndrome With Co-existing DNA (Cytosine-5)-Methyltransferase 3A Mutation Complicated by Localized Skin Reaction to Tocilizumab and Azacitidine.
    Estes J; Malus M; Wilson L; Grayson PC; Maz M
    Cureus; 2023 Jun; 15(6):e39906. PubMed ID: 37404435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Episcleritis and periorbital edema secondary to VEXAS syndrome.
    Fanlo P; Román MLS; Fonollosa A; Ilarramendi J; Heras H; Grayson P
    Arch Soc Esp Oftalmol (Engl Ed); 2023 Oct; 98(10):607-610. PubMed ID: 37595794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. VEXAS and Myelodysplastic Syndrome: An Interdisciplinary Challenge.
    Kreutzinger V; Pankow A; Boyadzhieva Z; Schneider U; Ziegeler K; Stephan LU; Kübke JC; Schröder S; Oberender C; le Coutre P; Stintzing S; Jelas I
    J Clin Med; 2024 Feb; 13(4):. PubMed ID: 38398362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Manifestations in Vacuoles, E1 Enzyme, X-Linked, Autoinflammatory, Somatic (VEXAS) Syndrome: A Narrative Review.
    Padureanu V; Marinaș CM; Bobirca A; Padureanu R; Patrascu S; Dascalu AM; Bobirca F; Tribus L; Alexandru C; Serboiu C; Dumitrascu C; Musetescu A
    Cureus; 2024 Jan; 16(1):e53041. PubMed ID: 38410307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. VEXAS syndrome (vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic): clinical review in a rapidly emerging field.
    Phan L; Hammond D; Wilson NR; Groarke EM; Patnaik MM; Pemmaraju N
    Leuk Lymphoma; 2024 May; ():1-13. PubMed ID: 38770970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. VEXAS syndrome: A review of cutaneous findings and treatments in an emerging autoinflammatory disease.
    Saad AJ; Patil MK; Cruz N; Lam CS; O'Brien C; Nambudiri VE
    Exp Dermatol; 2024 Mar; 33(3):e15050. PubMed ID: 38469984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. JAK inhibitors for the treatment of VEXAS syndrome.
    Bindoli S; Baggio C; Doria A; Bertoldo E; Sfriso P
    Exp Biol Med (Maywood); 2023 May; 248(5):394-398. PubMed ID: 37243340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.